Evolving Role of Biomarkers in Prostate Cancer : Episode 7
Opinion
Video
Challenges in Risk Assessment and Biomarkers in Treatment Recommendations
The panelists examine the challenges and limitations they've faced when using the Gleason score for risk assessment in prostate cancer patients, while also highlighting how biomarker testing has informed and guided their treatment strategies.
Video content above is prompted by the following question:
- What are some challenges or limitations you have encountered when using the Gleason score when assessing risk in your prostate cancer patients?
- In your clinical experience, have biomarkers guided your treatment recommendations? If so which one(s)?
Related Videos
Related Content
